![]() |
ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO
Celgene International SÃ*rl today announced that results from two investigator initiated studies including ABRAXANE, and bevacizumab in unresectable melanoma were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.
More... |
| All times are GMT -7. The time now is 07:57 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021